Regulatory role of CCN3 in melanoma cell interaction with the extracellular matrix

Cell Adhesion and Migration

Volumn 3, Issue 1, 2009, Pages 7-10

  Vallacchi, Viviana ^a   Rodolfo, Monica ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

CCN3 NOV; ECM; Fibulins; Matricellular proteins; Melanoma; Tumor microenvironment

Indexed keywords

CELL PROTEIN; CYSTEINE; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; REGULATOR PROTEIN; SCLEROPROTEIN; SOMATOMEDIN BINDING PROTEIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

CELL INTERACTION; EXTRACELLULAR MATRIX; HUMAN; MELANOMA CELL; NEPHROBLASTOMA; NOTE; REGULATORY MECHANISM; STROMA CELL; STRUCTURE ANALYSIS; TUMOR CELL;

EID: 67049145082     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.3.1.6836     Document Type: Note

References (30)

1. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004; 363:62-64
2. Kunz M, Moeller S, Koczan D, Lorenz P, Wenger RH, Glocker MO, et al. Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem 2003; 278:45651-45660
3. Vallacchi V, Daniotti M, Ratti F, Di Stasi D, Deho P, De Filippo A, et al. CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma. Cancer Res 2008; 68:715-723
4. Fukunaga-Kalabis M, Martinez G, Telson SM, Liu ZJ, Balint K, Juhasz I, et al. Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Oncogene 2008; 27:2552-2560
5. Fukunaga-Kalabis M, Martinez G, Liu ZJ, Kalabis J, Mrass P, Weninger W, et al. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J Cell Biol 2006; 175:563-569
6. Lazar N, Manara C, Navarro S, Bleau AM, Llombart-Bosch A, Scotlandi K, et al. Domain-specific CCN3 antibodies as unique tools for structural and functional studies. J. Cell Commun Signal 2007; 1:91-102.
7. Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M, et al. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 2005; 24:4349-4361
8. Planque N, Long Li C, Saule S, Bleau AM, Perbal B. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins. J Cell Biochem 2006; 99:105-116
9. Bleau AM, Planque N, Lazar N, Zambelli D, Ori A, Quan T, et al. Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation. J Cell Biochem 2007; 101:1475-1491
10. McCallum L, Price S, Planque N, Perbal B, Pierce A, Whetton AD, et al. A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood 2006; 108:1716-1723
11. Subramaniam MM, Lazar N, Navarro S, Perbal B, Llombart-Bosch A. Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies. Virchows Arch 2008; 452:33-39
12. Lázár-Molnár E, Hegyesi H, Tóth S, Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 2000; 12:547-554
13. Perbal B. New insight into CCN3 interactions-nuclear CCN3: fact or fantasy? Cell Commun Signal 2006; 4:6.
14. Kuphal S, Bauer R, Bosserhoff AK. Integrin signaling in malignant melanoma. Cancer Metastasis Rev 2005; 24:195-222.
15. Perbal B. The CCN3 protein and cancer. Adv Exp Med Biol 2006; 587:23-40.
16. Fukunaga-Kalabis M, Santiago-Walker A, Herlyn M. Matricellular proteins produced by melanocytes and melanomas: in search for functions. Can Microenviro 2008; 1:93-102.
17. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett 2006; 244:143-163
18. Kääriäinen E, Nummela P, Soikkeli J, Yin M, Lukk M, Jahkola T, et al. Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin and procollagen-I forming specific channel structures for invasion. J Pathol 2006; 210:181-191
19. Bellahcène A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 2008; 8:212-226
20. Rangel J, Nosrati M, Torabian S, Shaikh L, Leong SP, Haqq C, et al. Osteopontin as a molecular prognostic marker for melanoma. Cancer 2008; 112:144-150
21. Clark CJ, Sage EH. A prototypic matricellular protein in the tumor microenvironment- Where there's SPARC, there's fire. J Cell Biochem 2008; 104:721-732
22. Prada F, Benedetti LG, Bravo AI, Alvarez MJ, Carbone C, Podhajcer OL. SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth. J Invest Dermatol 2007; 127:2618-2628
23. Timpl R, Sasaki T, Kostka G, Chu ML. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 2003; 4:479-489
24. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003; 33:49-54.
25. Morin PJ. Drug resistance and the microenvironment: nature and nurture. Drug Resist Updat 2003; 6:169-172
26. Perbal B, Zuntini M, Zambelli D, Serra M, Sciandra M, Cantiani L, et al. Prognostic value of CCN3 in osteosarcoma. Clin Cancer Res 2008; 14:701-709
27. Pupa SM, Giuffré S, Castiglioni F, Bertola L, Cantú M, Bongarzone I, et al. Regulation of breast cancer response to chemotherapy by fibulin-1. Cancer Res 2007; 67:4271-4277
28. Böhlig L, Metzger R, Rother K, Till H, Engeland K. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor. Cell Cycle 2008; 7:1254-1261
29. Keshet GI, Goldstein I, Itzhaki O, Cesarkas K, Shenhav L, Yakirevitch A, et al. MDR1 expression identifies human melanoma stem cells. Biochem Biophys Res Commun 2008; 368:930-936
30. Gupta R, Hong D, Iborra F, Sarno S, Enver T. NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells. Science 2007; 316:590-593